Transparency Market Research
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 06-Feb-2014
122 Page Report
Buy Now
Request Sample
Press Release Molecular Diagnostics Market to Register a 11.1% CAGR from 2013 to 2019: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 Transparency Market Research has published a new market report based on “Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019” in addition to its comprehensive database. According to this report, the global molecular diagnostics market was valued at US$4.3 billion in 2012. The molecular diagnostics market is considered as one of the most attractive and well-established market for clinical applications. The molecular diagnostics market is expected to grow at a CAGR of 11.1% in the forecast period, 2013 to 2019 and reach an estimated value of US$8.7 billion by 2019. Indeed, our generation has invented some of the most innovative ideas in biotechnology which is observed in the form of molecular diagnostics. Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html Earlier, the use of molecular diagnostics was limited due to high cost of tests and need for highly skilled professionals. However, with recent reduction in labor cost, cost per sample analysis, improvements in advanced technologies and automation – have all stirred substantial growth in the molecular diagnostics market and the usage of molecular diagnostics tests. Today, the molecular diagnostics market is not only a rapidly growing segment but is a market that is highly supported by increasing research and development activities for biomarker identification coupled with introduction of new application of molecular tests. The growth in the molecular diagnostics market segment is also being supported by low costs, rapid turnaround time, high sensitivity and easy workflow. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1783 Currently, molecular diagnostics forms relatively a minor portion of the whole diagnostics market, but is identified and anticipated to be the next fastest growing sector in the forecast period. The report observes the molecular diagnostics market as the fastest growing sector of the in-vitro diagnostics market. Since, molecular diagnostics is defined as a class of diagnostic test that explores, identifies, and evaluates genetic, nucleic acids, proteins and molecular biomarkers at a molecular level; molecular diagnostic tests are placed in the fast lane development so that all the critical and emergency medical procedures are carried out promptly. Browse More Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html With increasing investments in R&D, rising chronic infections, increasing demand for personalized medicines, growing geriatric population, and rise in other R&D activities for biomarker identification, growth in the molecular diagnostics market soars. Now-a-days, the molecular diagnostics tests are performed for testing various infectious diseases such as, cancer testing, HCV, HAI, HIV, HLA testing, HPV, genetic diseases, and many others. Infectious disease standalone captures around 60% of the total share of the molecular diagnostics applications market. The remaining one third is driven to blood donor screening and genetic testing.
The market has many molecular diagnostic kits available for blood donor screening testing and pharmacogenetics processes too. The report details the molecular diagnostics market based on different technologies and applications. The technology segment comprises transcription mediated amplification (TMA), hybridization technique, microarray, polymerase chain reaction (PCR), next generation sequencing and others. Technologically, polymerase chain reaction (PCR) segment accounts for the largest share in the market, followed by transcription mediated amplification (TMA). Together, both these technologies account for nearly 50% of the share of molecular diagnostics market. On the other hand, the next generation sequencing is likely to witness the highest growth in the forecast period. The molecular diagnostics market is geographically segmented into four regions, North America, Europe, Asia Pacific and Rest of the World (RoW). Of all, North America and Europe are two of the most advanced markets accounting for the majority of the market share of molecular diagnostics market. They are also the leading regions in terms of adoption of molecular diagnostic testing. In addition, rising awareness, increasing investments in proteomics and genomics, and global acceptance of personalized medicines with rising incidence of chronic diseases are some of the value driven factors of the molecular diagnostics market in these regions. The report also marks a substantial growth of more than 14% CAGR in Asia-Pacific region during the forecast period.
TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019) 2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Rising incidence of cancer cases 3.2.2 Aging population
3.2.3 Increase in incidence of chronic diseases 3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines 3.3 Market Restraints 3.3.1 Issues with reimbursement policies 3.4 Market Opportunities 3.4.1 Technological advancements 3.4.2 Tapping the emerging economies 3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of New Entrants 3.5.4 Threat of Substitutes 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
Chapter 4 Molecular Diagnostics Market, by Technology 4.1 Overview 4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 4.2 Polymerase Chain Reaction (PCR) 4.2.1 Global PCR Market, 2011 – 2019 (USD Million) 4.3 Transcription Mediated Amplification (TMA) 4.3.1 Global TMA Market, 2011 – 2019 (USD Million)
4.4 Microarray 4.4.1 Global Microarray Market, 2011 – 2019 (USD Million) 4.5 Hybridization (ISH and FISH) 4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million) 4.6 Next-generation sequencing 4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million) 4.7 Others 4.7.1 Global Others Market, 2011 – 2019 (USD Million)
Chapter 5 Global Molecular Diagnostics Market, by Applications 5.1 Overview 5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million) 5.2 Infectious Diseases 5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million) 5.2.2 Virology 5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million) 5.2.2.2 Human immunodeficiency virus (HIV) testing 5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million) 5.2.2.3 Human papillomavirus (HPV) testing 5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million) 5.2.2.4 Hepatitis C virus (HCV) testing 5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million) 5.2.2.5 Others 5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.2.3 Bacteriology
5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million) 5.2.3.2 Hospital Acquired Infection (HAI) testing 5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million) 5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing 5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million) 5.2.3.4 Others 5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.3 Genomics 5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million) 5.3.2 Genetic testing for inherited disorders 5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million) 5.3.3 Human Leukocyte Antigen (HLA)testing 5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million)
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
5.3.4 Pharmacogenetics testing 5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million) 5.3.5 Oncology testing 5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million) 5.4 Blood Donor Screening 5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million) 5.5 Others 5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
Chapter 6 Global Molecular Diagnostics Market, by Geography 6.1 Overview 6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million) 6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %) 6.3 North America 6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.4 Europe 6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.5 Asia-Pacific 6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.6 RoW 6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
Chapter 7 Global Molecular Diagnostics Market Share Analysis 7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market 7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%) 7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market
Chapter 8 Recommendations 8.1 Market Strategies for Success
8.1.1 Long term contracts with healthcare service providers 8.1.2 Investing in emerging economies such as China, India and Russia 8.1.3 Broadening of distribution network
Chapter 9 Company Profiles 9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Financial Overview 9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments 9.2 Becton Dickinson & Company 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments 9.3 bioMerieux 9.3.1 Company Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Bio-Rad 9.4.1 Company Overview
9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies 9.4.5 Recent Developments
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
9.5 Cepheid 9.5.1 Company Overview 9.5.2 Financial Overview 9.5.3 Product Portfolio 9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Danaher Corporation (Beckman Coulter) 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.6.5 Recent Developments 9.7 F. Hoffmann-La Roche Ltd. 9.7.1 Company Overview 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies
9.7.5 Recent Developments 9.8 Hologic, Inc. (Gen-Probe) 9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio 9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 Myriad Genetics, Inc. 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments 9.10 Novartis International AG 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.11 Qiagen 9.11.1 Company Overview 9.11.2 Financial Overview 9.11.3 Product Portfolio 9.11.4 Business Strategies 9.11.5 Recent Developments 9.12 Quest Diagnostics, Inc.
9.12.1 Company Overview 9.12.2 Financial Overview 9.12.3 Product Portfolio 9.12.4 Business Strategies 9.12.5 Recent Developments
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
9.13 Siemens AG 9.13.1 Company Overview 9.13.2 Financial Overview 9.13.3 Product Portfolio 9.13.4 Business Strategies 9.13.5 Recent Developments 9.14 Thermo Fisher Scientific 9.14.1 Company Overview 9.14.2 Financial Overview 9.14.3 Product Portfolio 9.14.4 Business Strategies 9.14.5 Recent Developments About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/